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Abstract
Background: PPFIA1 is located at the 11q13 region commonly amplified in cancer. The protein liprin-α1 encoded
by PPF1A1 contributes to the adhesive and invasive structures of cytoskeletal elements and is located at the invadosomes
in cancer cells. However, the precise mechanism of liprin-α1 function in cancer progression has remained elusive.
Methods: Invasion regulating activity of liprin-α1 was examined by analyzing the functions of squamous cell carcinoma
of head and neck (HNSCC) cell lines in three-dimensional collagen I after RNAi mediated gene knockdown. Transcriptome
profiling and Gene Set Enrichment Analysis from HNSCC and breast cancer cells were used to identify expression changes
relevant to specific cellular localizations, biological processes and signaling pathways after PPFIA1 knockdown. The
significance of the results was assessed by relevant statistical methods (Wald and Benjamini-Hochberg). Localization of
proteins associated to liprin-α1 was studied by immunofluorescence in 2D and 3D conditions. The association of
PPFIA1 amplification to HNSCC patient survival was explored using The Cancer Genome Atlas data.
Results: In this study, we show that liprin-α1 regulates biological processes related to membrane microdomains in
breast carcinoma, as well as protein trafficking, cell-cell and cell-substrate contacts in HNSCC cell lines cultured in
three-dimensional matrix. Importantly, we show that in all these cancer cells liprin-α1 knockdown leads to the
upregulation of transmembrane protein CD82, which is a suppressor of metastasis in several solid tumors.
Conclusions: Our results provide novel information regarding the function of liprin-α1 in biological processes
essential in cancer progression. The results reveal liprin-α1 as a novel regulator of CD82, linking liprin-α1 to the
cancer cell invasion and metastasis pathways.
Keywords: Liprin-α1, PPFIA1, CD82, Head and neck cancer, Breast cancer, Invasion, RNA sequencing, Three-dimensional
cell culture
Background
PPFIA1 is located at the 11q13 amplification region [1]
which is related to poor prognosis of the patients in several
cancers, including head and neck squamous cell carcinoma
(HNSCC) and breast cancer [2–4]. PPFIA1 encodes
liprin-α1 protein, which is a member of the liprin protein
family of tyrosine phosphatase interacting proteins
conserved in evolution [5, 6]. Liprin-α proteins have
been studied extensively in neurons with reported in-
volvement in synapse functions [7–10].
In addition to the functions in neuronal cells, liprin-α1
has been associated to cancer metastases [11], cell migra-
tion and invasive growth [12, 13]. Of note, liprin-α1 affects
cancer cell spreading, the distribution of cell surface β1-
integrins [14], and regulates cell edge dynamics and focal ad-
hesion assembly in motile epithelial cancer cells via proteins
including vimentin, ERC1 (ELKS/RAB6-interacting/CAST
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family member 1) and β1-integrin [12, 15]. We have recently
shown that in non-invasive cancer cells liprin-α1 locates to
invadosome structures and promotes growth behavior with
limited invasive capacity [12], whereas in invasive and motile
cancer cells liprin-α1 is essential for mesenchymal can-
cer cell invasion and regulation of extracellular matrix
degradation [12, 13]. Besides the cancer promoting
functions, liprin-α1 has been recently implicated in re-
cycling of active α5β1 in fibronectin polymerization-
dependent vascular morphogenesis [16]. These results
suggest several important cellular functions of liprin-α1
in both neuronal and epithelial cancer cells.
In the present study, our aim was to explore the cellular
liprin-α1 functions in three-dimensional (3D) collagen I
matrix environment, and to identify genes and molecular
mechanisms that are involved in liprin-α1 mediated regu-
lation of cell invasive growth. Our results revealed a
unique interplay between liprin-α1 and CD82 transmem-
brane protein in the invasion of HNSCC and breast cancer
cells, thus providing mechanistic details of liprin-α1 func-
tion in cancer cell progression.
Methods
Cell lines and reagents
Two breast cancer cell lines MDA-MB-231 from meta-
static breast adenocarcinoma and Hs578T cell line from
breast carcinoma (ATCC, American Type Culture Collec-
tion, Manassas, MD, USA) were studied. HNSCC cell lines
UT-SCC-42A from laryngeal cancer, UT-SCC-42B from
corresponding neck metastasis, UT-SCC-19B from laryn-
geal persistent cancer and UT-SCC-24B from neck metas-
tasis of tongue cancer were derived from clinical samples
(Reidar Grénman, Department of Otorhinolaryngology –
Head and Neck Surgery, Turku University Hospital,
Finland). UT-SCC and MDA-MB-231 cell lines were
cultured using Dulbecco’s Modified Eagle’s Medium
(DMEM) (Lonza, Verviers, Belgium) with an added 2mM
of L-glutamine, 0.1 mM of non-essential amino acids
(NEAA) (Lonza), penicillin/streptomycin antibiotics (100
U/ml) (Lonza) and 10% fetal bovine serum (FBS) (Gibco).
The Hs578T cell line was cultured using RPMI-1640
medium (Lonza) with the same supplements added as
with the DMEM.
Constructs and lentiviral transduction
Lentiviral particles were generated for shRNA constructs
from the TRC1 library (Sigma-Aldrich, St. Louis, Missouri,
U.S.) targeting PPFIA1 and VIM. Constructs for PPFIA1 were
TRCN0000342514, TRCN0000380944, TRCN0000002969,
and TRCN0000380097, named as shPPFIA1_14, shPPFIA1_
44, shPPFIA1_69 and shPPFIA1_97, and for VIM they were
TRCN0000029119 and TRCN0000029121 (Sigma-Aldrich,
St. Louis, Missouri, U.S.). The shRNA was cloned into the
pLKO.1 vector with the puromycin resistance gene. Lentiviral
particles carrying the shRNA constructs for genes of interest
and shScramble (shScr) used as a control were generated at
the Biomedicum Functional Genomics Unit (FuGU, Univer-
sity of Helsinki, Finland). Transduction of each cell line was
performed as briefly described: cells were counted at 100,000
cells/ml, seeded into 12-well plates, incubated overnight, and
infected with the lentiviral particles. Selection for the
infected shRNA cells was done by using 1 μg/ml puro-
mycin (Sigma-Aldrich).
Antibodies
Primary antibodies used for immunofluorescence or west-
ern blotting were mouse monoclonal α-tubulin (Sigma-
Aldrich, St. Louis, Missouri, U.S), mouse monoclonal
vinculin (Sigma-Aldrich, St. Louis, Missouri, U.S.), rabbit
polyclonal liprin-α1 (Proteintech, Manchester, U.K.), mouse
monoclonal CD82 (Abcam, Cambridge, U.K.), rabbit
monoclonal sortilin-related receptor 1 (SORL1) (Cell
Signaling, Danvers, Massachusetts, U.S.), mouse monoclo-
nal vimentin (Sigma-Aldrich, St. Louis, Missouri, U.S.),
mouse monoclonal cytokeratin-13 and rabbit monoclonal
cytokeratin-4 (Abcam, Cambridge, U.K.), rabbit polyclonal
cytokeratin-13 and rabbit polyclonal cytokeratin-4 (Pro-
teintech, Manchester, U.K.), mouse monoclonal cytokera-
tin 10 (Invitrogen, Thermo-Fisher Scientific, Rockford,
U.S.), goat polyclonal actin (Abcam, Cambridge, U.K.),
rabbit monoclonal EEA1 3288 (Cell Signaling), rabbit
monoclonal caveolin-1 (D46G3) (Cell Signaling), rabbit
polyclonal ZO-1 (Invitrogen). Alexa Fluor phalloidin 488
and 594 (Invitrogen, Thermo-Scientific, Eugene, OR, U.S.)
were used to stain the actin cytoskeleton. As secondary
antibodies, Alexa Fluor 488 or 594 F(ab’) 2 fragment of
goat anti-mouse IgG (H + L) and Alexa Fluor 488 or
594 F(ab’) 2 fragment of goat anti-rabbit IgG (H + L)
(Invitrogen, Eugene, OR, U.S.) were used for immuno-
fluorescence microscopy. For immunoblotting, second-
ary antibodies horseradish peroxidase (HRP) conjugate
goat anti-mouse IgG (H + L) (Life Technologies, Rockford,
IL, U.S.), HRP conjugate goat anti-rabbit IgG (H + L) (Life
Technologies, Rockford, IL, U.S.), and HRP conjugate
rabbit anti-goat IgG (Abcam, Cambridge, U.K.) were used.
Immunoblotting
Cells were grown until they reached 70–80% confluency
and lysed using lysis buffer (radioimmunoprecipitation
buffer, RIPA) (Sigma-Aldrich, Rockford, IL, U.S.), including
protease (complete protease inhibitor cocktail, Roche,
Mannheim, Germany) and phosphatase inhibitors (phos-
phatase inhibitor cocktail, Roche). The lysates were agi-
tated at + 4 °C for 10 min, incubated on ice for 30 min,
resuspended gently and centrifuged at 14,000 g after
which the supernatants were collected. Protein concen-
tration was measured with an RC DC Protein Assay Kit
(BioRad). Loading buffer with 5% β-mercaptoethanol
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and 2 x Laemmli buffer (BioRad) was added to each sam-
ple. Samples were denatured by boiling at + 95 °C for
5 min. For non-reducing conditions β-mercaptoethanol
and boiling were excluded. Samples were loaded into the
SDS gels (BioRad), from which proteins were transferred to
polyvinylidene fluoride (PVDF) membranes (BioRad) using
Transfer Blot Turbo (BioRad) equipment. Membranes were
incubated at room temperature in a blocking solution con-
sisting of 5% milk powder or 5% bovine serum albumin
(BSA) in tris-buffered saline and Tween (TBST) followed
by TBST washes. Membranes were incubated with primary
antibodies for 1 h at room temperature or overnight at +
4 °C with shaking. After incubation, the membranes were
washed with TBST followed by incubation with secondary
antibody for 1 h and washing with TBST. Finally, the mem-
branes were incubated with detection reagents (Millipore)
for two minutes. Chemiluminescence signals were detected
on X-ray films (Kodak) or by using Chemidoc Imaging Sys-
tem (BioRad). Quantification of western blot was measured
by ImageLab (BioRad) or by ImageJ, and statistical signifi-
cance was measured with student’s t-test and error bars as
standard deviations. Constructs with efficient knockdown
were used in quantification of protein levels.
Cell culture and immunofluorescence
For three-dimensional (3D) invasive growth assay, cells
were grown on type I collagen (2.2 mg/ml, Sigma). Im-
munofluorescence for two-dimensional (2D) and 3D
cultures and quantification of 3D cell cultures were per-
formed as previously described [12, 17]. Alternatively,
40,000 cells/ml were counted and embedded into collagen
I drops (Gibco, Life Technologies) in a 24-well plate and
incubated for seven days changing medium every day.
The cells were fixed using 4% paraformaldehyde in
phosphate-buffered saline (PBS), followed by two washes
with PBS. Permeabilization was done using 0.25%
Triton-X, after which the cells were washed with PBS, in-
cubated with 0.12% glycin, 0.25% Tx-100 in PBS and
washed with 0.25% Tx-100 in PBS. After blocking the cells
for 60 min in 3% bovine serum albumin (BSA) 0. 25%
Tx-100 in PBS or in 15% FBS, 0.3% Tx-100 in PBS (2 h,
RT), they were incubated in primary antibody diluted in
1:100 or 1:200 with 3% BSA, 0.25% Triton-X in PBS or in
15% FBS, 0.3% TX-100 in PBS 1 h-overnight at + 4 °C in
shaking. The cells were then washed with 0.25–0.45%
Triton-X in PBS followed by incubation in a secondary
antibody using dilution of 1:400 in 3% BSA, 0.25%
Triton-X in PBS or in 15% FBS, 0.3% Tx-100 in PBS for
one to four hours with shaking in dark at RT. The cells
were washed with 0.25–0.45% Triton-X in PBS mini-
mum three times over several hours and milli-Q water
two times with shaking followed by washes with PBS
for one hour to overnight. Collagen I drops were
mounted in Mowiol containing 1.4-diazabicyclo (2.2.2)
octane (DABCO) and 4′6-diamidino-2-phenylindole
(DAPI) (Sigma) for nucleus staining.
Microscopy
Confocal images were taken using a Zeiss Meta 780/880
laser scanning microscope with a Zeiss 40× or a 63×/
1.4 N.A. plan-apochromat oil objective, and adjusted and
background corrected with ZenLite (2.3 Lite), Adobe
Photoshop CS6, Illustrator CS6 software, Corel and/or
ImageJ. Brightness and contrast were linearly adjusted
using ZEN 2012 (blue edition; Carl Zeiss), Adobe
Photoshop CS6 or Photo-Paint X7 (Corel). Single optical
sections were used for image display. Three-dimensional
collagen contraction images were taken using light mi-
croscopy (Leica MZ FLIII). Image editing was done with
Adobe Photoshop CS6 and Illustrator CS6 software.
Co-localization analysis
For co-localization analysis, the confocal images were
deconvolved, thresholded by the Costes method and ana-
lyzed by the Pearson’s correlation coefficient with Huygens
Professional version 18.04 (Scientific, __http://svi.nl__).
Three-dimensional (3D) cell culture for RNA sequencing
A total of 300,000 cells/ml were counted and mixed with
collagen I (Gibco, Life Technologies) diluted in 10 x PBS
(Lonza), 1 M NaOH and sterile milliQ water according
to manufacturer’s instructions (Gibco, Life Technologies).
Collagen I / cell suspension was plated into the 24-well
low adhesion plates for the final volume of 500 μl. The
collagen I / cell suspension was incubated at + 37 °C for
30 min, after which medium was added on top and
changed daily. Cells in collagen I gels were grown for
five days after which they were further processed for RNA
sequencing. For HNSCC cell lines, the plates were
coated with poly(2-hydroxyethyl methacrylate)/poly-HEMA
(Sigma-Aldrich) to avoid two-dimensional cell growth and
attachment of the cells to the bottom of the plates.
Collagen contraction and spheroid formation assays
Collagen gel contraction model is a method to estimate
cell mediated contracture of the ECM in vitro [18].
MDA-MB-231 control and liprin-α1 knockdown cells
were grown in collagen I using the same protocol than
in 3D cell culture. Low adhesion 24-well plates were
used as cell culture plates. Cell suspensions in collagen I
were imaged using optical microscope (Leica MZ FLIII)
on days 1, 2, 5 and 6. Relative cell area was calculated
using ImageJ software. For spheroid formation assay,
10,000 cells were counted and plated on U bottom
96-well low-adhesion plates and spheroid formation was
monitored using light microscope.
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RNA isolation and removal of ribosomal RNA
One milliliter of Trizol (Life Technologies) was added to
cell/collagen I mixture which was further mixed with
the Precellys ceramic beads followed by homogenization
with a homogenisator (Precellys). 0.2 ml of chloroform
(Fisher Scientific, Hampton, New Hampshire, US) was
added to the samples followed by shaking the samples
manually for 15 s. After 2 min incubation in room
temperature, the samples were centrifuged at 11,300 rpm
for 15 min at + 4 °C. Upper bright phase was kept, 0.5 ml
of isopropanol (Fisher Scientific) was added and the solu-
tion was mixed. The samples were incubated for 10 min in
room temperature and centrifuged at 11,300 rpm for
10 min at + 4 °C after which 1 ml of 75% ethanol (Etax)
was added. The samples were mixed and centrifuged at
8800 rpm for 5 min at + 4 °C. Pellets were dissolved to
Rnase-free water (Lonza AccuGENE Molecular biology
Grade Water) at + 55 °C for 10 min. Isolated RNA was
purified using Qiagen RNeasy Mini kit according to Qia-
gen protocol (Qiagen, Hilden, Germany). Ribosomal RNA
was removed by using RiboZero Complete Gold Human
kit (Illumina, San Diego, California, US) according to man-
ufacturer’s instructions. Similarly, the second strand cDNA
synthesis (NEBNext, Illumina, San Diego, California, US)
and purification of double-stranded cDNA by 1.8X
Agencourt AMPure XP beads were carried out accord-
ing to manufacturers’ instructions (Illumina, San Diego,
California, US).
Library preparation
For library preparation, NEBNext Directional RNA library
kit was used according to manufacturer’s instructions
(Illumina, San Diego, California, US). The PCR amplified
library was purified using Agencourt AMPure XP beads
according to manufacturer’s instructions (Illumina, San
Diego, California, US). The quality of the sequencing
library was assessed using Bioanalyzer (Agilent High
Sensitivity Chip) and concentrations were measured by
Qubit. Library denaturation and dilution were made
according to NextSeq 500 system guide (Illumina). Sam-
ples were loaded onto the Illumina NextSeq 500 High
75 bp reagent cartridge for RNA sequencing.
RNA sequencing data analysis
RNA-seq data was pre-processed using QualiMap, FastQC,
STAR aligner, and trimmomatic software. Differential ex-
pression analysis was performed by DESeq2 package R
v3.2.3 and results underwent logarithmic transformation.
Statistical significance of the gene expression changes be-
tween liprin-α1 knockdown (shPPFIA1) and control cells
(shScr) was evaluated by Wald test. Significantly differen-
tially expressed genes were considered those with corrected
p-values padj < 0.05 (Benjamini-Hochberg). Three dif-
ferent biological replicates per cell line (UT-SCC-42A,
UT-SCC-42B, MDA-MB-231) were studied. The RNA
sequencing data have been deposited in The National
Center for Biotechnology Information’s (NCBI’s) Gene
Expression Omnibus (GEO, Series accession number
GSE108392). In addition, we compared the current RNA
sequencing data to our previously published UT-SCC-24B
cell line hybridized on Affymetrix GeneChip Human
Exon 1.0 ST gene expression microarrays (GEO Series
accession number GSE75756) [12]. Genes that were
differentially expressed due to liprin-α1 silencing in
different conditions and cell lines were compared using
Venn diagrams by Venny 2.1 analysis program (http://
bioinfogp.cnb.csic.es/tools/venny/index.html). Gene ex-
pression data for each sample and condition can be
found in Gene Expression Omnibus under accession
numbers described above.
Gene set enrichment analysis (GSEA) data analysis
Gene set enrichment analysis [19, 20] was used to study
whether a priori defined set of genes showed statistically
significant, analogous differences between control (shScr)
and liprin-α1 (shPPFIA1) knockdown cells. The enrich-
ment score (ES) was the result of a gene set enrichment
analysis, and reflected how overrepresented the gene set
was at the top or bottom of a ranked gene listing. Path-
ways were ranked by their normalized enrichment score
(NES), and were considered significant if their q- and
p-values were under 0.05. False discovery rate (FDR) signi-
fied the probability of a false positive finding and the nom-
inal p-value stated the statistical significance of the ES for
the gene set [19, 20].
Knock-down of CD82 by siRNAs
For knocking-down CD82 in shPPFIA1 HNSCC cells by
using a siRNA pool for CD82 (Sigma-Aldrich), UT-SCC-
42B cells were counted at 200000/ml, and seeded to six
well plates. Cells were grown overnight and siRNA
transfection was performed. Transfection reagents used
were Lipofectamine RNAiMAX (Thermo-Fisher) and
Opti-MEM (Thermo-Fisher). Transfection experiment
was performed according to manufacturer’s instructions
(Thermo-Fisher). Western blot was performed to verify
the efficiency of knock-down. Control cells and CD82
knockdown cells were counted (40,000) and embedded
to collagen I (Gibco), and were monitored and incubated
for seven days, after which colonies were fixed with 4%
PFA and stained with phalloidin. Colonies were quantified
by ImageJ and average area of colonies from three repli-
cates/condition was calculated. Error bars were calculated
as standard deviation, and statistical significance was mea-
sured by unpaired student’s t-test with three different rep-
licates/condition.
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Results
Liprin-α1 promotes invasive cellular growth in metastatic
head and neck squamous cell carcinoma cells
Based on our previous results showing the function of
liprin-α1 in promoting invasive growth of invasive breast
cancer cells in 3D collagen environment [12], we ex-
plored whether liprin-α1 regulates invasive growth of
the highly invasive UT-SCC-42B from metastasis and
UT-SCC-19B from primary persistent HNSCC cells as
well. UT-SCC-42B cells embedded in 3D collagen I and
transduced with shRNA targeting PPFIA1 reduced cell
invasive growth compared to shScr cells, measured as
relative growth area of the cells after seven days in cul-
ture (Fig. 1a-b). Knockdown of PPFIA1 led to a less inva-
sive cell phenotype also in UT-SCC19B (Fig. 1a-b), but
the relative growth area was not significantly altered as
compared to the control cells. The liprin-α1 silencing
was also more efficient in UT-SCC-42B compared to the
11q13 positive UT-SCC-19B cell line (Fig. 1c). Liprin-α1
knockdown led to reduced lumen formation, actin cyto-
skeleton rearrangements and reduced F-actin containing
cellular outgrowths in the UT-SCC-42B cell colonies
(Fig. 1d-e).
In control cells, liprin-α1 was enriched at the cell colony
edge in F-actin and/or vinculin containing structures pro-
truding into the collagen matrix (Fig. 1f-g, Additional file 1:
Figure S1). Especially in the lumen-forming UT-SCC-42B
cell colonies, liprin-α1 was concentrated to the outer sur-
face of the colony (Fig. 1f, Additional file 1: Figure S1).
Liprin-α1 knockdown resulted in differential expression of
102 shared genes in HNSCC and breast cancer cells
To understand the molecular mechanisms of liprin-α1
in cell adhesion and invasive growth properties, we car-
ried out RNA sequencing to explore gene expression
changes after PPFIA1 knockdown. The metastatic breast
cancer cell line MDA-MB-231, laryngeal UT-SCC-42A
obtained from primary tumor, and UT-SCC-42B ob-
tained from corresponding neck metastasis were trans-
duced using three different shRNA constructs targeting
liprin-α1. In MDA-MB-231 breast cancer cells, there
were 592 significantly differentially expressed genes after
liprin-α1 knockdown compared to control cells whereas
in UT-SCC-42A and UT-SCC-42B cell lines 1745 genes
were significantly differentially expressed, when p-value
was set under 0.05 (Additional file 2: Table S1 and
GSE108392). A total of 102 shared genes were differen-
tially expressed in both the breast cancer and HNSCC
cell lines, when 592 genes from MDA-MB-231 cell line
and 1000 genes from HNSCC data were selected with
the most significant p-values (Fig. 2a, Additional file 3:
Table S2A). To explore the influence of liprin-α1 silencing
to gene expression patterns in different cell lines and cell
culture platforms (2D vs 3D), microarray and RNA-seq
data from HNSCC and breast cancer cell lines were com-
pared (Fig. 2b, GEO Series accession numbers GSE108392
and GSE75756 [12]). A total of 61 differentially expressed
genes were shared between two different HNSCC cell lines
grown in 2D and 3D conditions (Fig. 2b, Additional file 3:
Table S2B), whereas 26 shared genes showed differen-
tial expression between shPPFIA1 and shScr samples in
HNSCC cells grown in 2D and breast cancer cells in
3D as demonstrated by the Venn diagram (Fig. 2b,
Additional file 3: Table S2C). Eleven shared genes showed
differential expression between shPPFIA1 and shScr sam-
ples in all different conditions as demonstrated by the
Venn diagram (Fig. 2b, Additional file 3: Table S2D).
Gene set enrichment analysis (GSEA) revealed involvement
of liprin-α1 in regulation of protein trafficking, cell-cell
junctions and membrane microdomains
Next, we studied the effect of liprin-α1 knockdown on
the gene expression of specific cellular pathways or gene
sets, which better encompasses the overall landscape of
the effect of liprin-α1 in the regulation of cell signaling
events in cancer cells. GSEA was performed to detect
sensitively the overall regulatory patterns derived from the
RNA sequencing data (Fig. 2c, Table 1, Additional file 4:
Table S3). Knockdown of liprin-α1 in HNSCC cells led to
changes in regulation of cell substrate junctions, anchor-
ing junctions (including ASAP3), regulation of vacuolar
transport (including SORL1), phosphatase complex, and
establishment or localization of proteins to membrane (in-
cluding ANXA2, SMURF1), or endoplasmic reticulum. In
breast cancer cells, GSEA data analysis revealed liprin-α1
in the regulation of membrane microdomains (including
TGFRB2), regulation of proteolysis (including SORL1,
FN1) and peptidase activity and regulation of morphogen-
esis of epithelium. In addition, knockdown of liprin-α1
had a negative effect on peptidase and hydrolase activity,
and positive effect on regulation of cell death (including
TP63) (Fig. 2c and Table 1). GSEA data suggests that
liprin-α1 has several crucial functions related to regula-
tion of cellular signaling events and protein trafficking
in cancer cells, which are related to the cell-cell or
cell-substrate junctions as well as to the composition of
the cell membrane. To strengthen the role of liprin-α1
in the junctional and cytoskeletal signaling, collagen
contraction analysis was performed with breast cancer
cells. Equal amount of control (shScr) and knockdown
(shPPFIA1) cells were counted and cells were allowed
to grow on low attachment plates inside collagen I for six
days. The relative contraction area of the collagen I gel
was measured. Collagen gels with control shScr cells were
significantly more contracted compared to collagen gels
with shPPFIA1 cells (Additional file 5: Figure S2A-C). In
addition, liprin-α1 knockdown cells plated without
matrix on a low adhesion 96-well plate, did not form
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tight spheroids opposite to control cells (Additional file 5:
Figure S2D). This data further signifies the role of
liprin-α1 in the junctional and cytoskeletal pathways.
Liprin-α1 suppresses tetraspanin CD82 expression
In the MDA-MB-231 cell line, CD82 was ranked among
the top of the upregulated genes in RNA sequencing
Fig. 1 UT-SCC-42B and UT-SCC-19B carcinoma cells were embedded in 3D collagen after shPPFIA1_69 or shScr (control) transduction and cultured for
seven days. a Representative phase contrast light micrographs showed less cellular outgrowths and invasive phenotype in colonies transduced with
shPPFIA1_69 compared to shScr control cells. b Quantification of cell invasive growth measured by relative area of the colonies; mean ± SEM; three
collagen preparations/stable control (shScr) or knockdown (shPPFIA1_69) cell line. *P < 0.001, unpaired Student’s t-test. c Western blot confirmed the
efficacy of liprin-α1 knockdown in UT-SCC-19B and UT-SCC-42B cell lines. d Quantification of relative colony and lumen area of UT-SCC-42B cells in 3D
collagen with shScr and shPPFIA1_97; mean ± SEM; three collagen preparations/stable control (shScr) or knockdown (shPPFIA1_97) cell line. *P < 0.01,
unpaired Student’s t-test. Scale bar 10 μm. e Lumen formation was diminished in liprin-α1 knockdown cell colonies compared to shScr cells as
visualized by Z-stacks. f Representative confocal micrographs illustrated liprin-α1 (green) localization in the cytosol and at the cell-extracellular matrix
contacts including focal adhesion-like cellular outgrowths. Phalloidin staining (filamentous actin, red) visualizes reduced growth and changes in
cytoskeletal elements after liprin-α1 knockdown. g Confocal micrographs showed vinculin localization at the cell colonies. Scale bar 50 μm
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analysis after liprin-α1 knockdown (Fig. 3a, Additional
file 2: Table S1) ((log2) fold change = 1.13, p-value =
5.37^-15) and was therefore selected for further studies.
Importantly, CD82 was also significantly altered in the
HNSCC dataset ((log2) fold change = 1.15, p-value = 0.018;
Additional file 6: Figure S3A, Additional file 2: Table S1).
Interestingly, SORL1 also showed differences in gene ex-
pression after liprin-α1 knockdown in breast cancer and in
HNSCC cell lines (Fig. 3a, Additional file 6: Figure S3A,
Additional file 2: Table S1) (SORL1; MDA-MB-231, p =
1.7^-15, (log2) fold change = 1.8, and HNSCC, p = 0.0099,
(log2) fold change = 1.1). Immunoblotting showed CD82
upregulation in different cell lines knocked down for
liprin-α1 (Fig. 3b-c). Interestingly, SORL1 protein ex-
pression levels were upregulated in HNSCC cell lines
after liprin-α1 knockdown (Fig. 3b-c). In MDA-MB-231
cell line, CD82 was localized either in vesicle-like struc-
tures or at the cell edge/membrane as detected in
Fig. 2 a Venn diagram showed a number of shared genes in UT-SCC-42A/B and MDA-MB-231 cell lines grown in 3D collagen I after liprin-α1
silencing. b Venn diagram illustrated the number of shared genes in UT-SCC-42A/B and MDA-MB-231 cell lines in 3D collagen I and in UT-SCC-24B
cell line grown in 2D cell culture after liprin-α1 silencing. c Selected clusters from pathway analysis comparing liprin-α1 knockdown (shPPFIA1) cells to
control cells (shScr). Ranking of the clusters was carried out by normalized enrichment scores (NES)
Pehkonen et al. Cell Communication and Signaling  (2018) 16:41 Page 7 of 14
dividing cells after liprin-α1 knockdown (Fig. 3d). Im-
munofluorescence from UT-SCC-42A cells cultured in
2D revealed that cells with liprin-α1 knockdown contained
CD82 positive vesicle-like structures or alternatively, CD82
was localized partly at the cell membrane, while liprin-α1
was detected in invadosome structures in shScr control
cells (Fig. 4a, Additional file 6: Figure S3B). CD82 co-local-
ized partly, but not prominently, with caveolin-1 positive
vesicles, whereas CD82 did not co-localize with early endo-
some marker EEA1 (Additional file 7: Figure S4). CD82
was neither co-localizing at the invadosomes, because it
was found at different z-stack planes as compared to
F-actin positive invadosome cores (Additional file 7:
Figure S4). When studying localization of CD82 in 3D
cell culture, it was localized at the cell membrane and
cell-cell junctions in liprin-α1 knockdown cells (Fig. 4b).
Localization to cell-cell contacts was verified with
co-localization of F-actin and zona occludens-1 (ZO-1)
positive structures (Additional file 8: Figure S5). Liprin-α1
was detected either cytosolic or near the cell edge in adhe-
sion or invadosome-like structures as illustrated in the
shScr control UT-SCC-42A cells (Fig. 4b). Downregula-
tion of CD82 by siRNAs partially enhanced invasive cap-
abilities of shPPFIA1_97 UT-SCC-42B cells in 3D collagen
I (Additional file 9: Figure S6).
Modulation of cytoskeletal elements by liprin-α1 in
cancer cells
Our previous results from metastatic UT-SCC-24B HNSCC
cell line grown in 2D cell culture [12] showed vimentin
upregulation in shPPFIA1 versus shScr cells. In the present
study, HNSCC cell lines cultured in 3D matrix VIM
was upregulated in both the RNA ((log2) fold change =
1.7, p = 0.0033, Additional file 6: Figure S3A, Additional
file 2: Table S1) and protein level (Additional file 10:
Figure S7A) in shPPFIA1 cells, which is in conjunction
with our previous results. Our previous findings by
microarrays showed liprin-α1 knockdown to repress
keratin intermediate filaments in metastatic UT-SCC-
24B cell line [12], which suggests that keratin network
compensates low endogenous vimentin expression in
certain types of HNSCC (Additional file 10: Figure S7B-C).
Next, we evaluated whether vimentin knockdown af-
fects liprin-α1 expression or localization. After knock-
ing down vimentin in MDA-MB-231 and Hs578T
breast cancer cells, which highly express endogenous
vimentin, liprin-α1 was not localized near the cell edge
or after the leading edge as in control cells, although
there were no significant changes at the protein expres-
sion levels in these breast cancer cell lines (Additional
file 10: Figure S7D-E). Vimentin knockdown had effect
on focal adhesion localization exemplified by cytoplas-
mic staining of vinculin after vimentin knockdown, and
lack of liprin-α1 localization at the vicinity of focal ad-
hesions (Additional file 10: Figure S7E). Vimentin knock-
down in these cells was not compensated by upregulating
keratin intermediate filaments. On the contrary, keratin
13 expression was decreasing after knockdown of
vimentin in breast cancer cell lines (Additional file 10:
Figure S7D). These results support our previous data
Table 1 Enriched gene sets in GSEA analyses in HNSCC and breast cancer cell lines after liprin-α1 knockdown cultivated in 3D
collagen I
Gene Set: HNSCC NES FDR q-value FWER p-value
GO cell substrate junction 2,49 0.000 0.000
GO establishment of protein localization to endoplasmic reticulum 2,47 0.000 0.000
GO protein localization to endoplasmic reticulum 2,45 0.000 0.000
GO anchoring junction 2,35 0.000 0.000
GO protein targeting to membrane 2,2 0.000 0.001
GO establishment of protein localization to organelle 2,14 0.001 0.011
GO regulation of vacuolar transport 2,09 0.001 0.022
GO phosphatase complex 2,08 0.002 0.025
GO establishment of protein localization to membrane 2,07 0.002 0.039
GENE SET: Breast cancer
GO negative regulation of hydrolase activity 2,74 0.000 0.000
GO regulation of proteolysis 2,54 0.007 0.006
GO negative regulation of peptidase activity 2,5 0.008 0.010
GO regulation of peptidase activity 2,44 0.008 0.013
GO membrane microdomain 2,42 0.008 0.018
GO positive regulation of cell death 2,33 0.016 0.041
GO morphogenesis of an epithelium 2,32 0.015 0.044
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on the effect of liprin-α1 knockdown to adhesion and
intermediate filament signaling. Furthermore, breast can-
cer cells with high endogenous vimentin expression were
incapable for mesenchymal invasion inside three dimen-
sional collagen I matrix after liprin-α1 knockdown due to
disorganized vimentin network [12].
Fig. 3 a Heat map of top ranked differentially expressed genes in shPPFIA1 vs shScr MDA-MB-231 cells using RNA sequencing. Genes were ranked based
on the p-value and fold change. Color coding from blue to red depicts gene expression differencies between shPPFIA1 and shScr cells from low to high
expression. b Gene expression analysis showed upregulation of SORL1 and CD82 at mRNA level in MDA-MB-231 cell lines, and western blot validation
showed upregulation of CD82 protein expression in breast and HNSCC cancer cell lines. SORL1 protein expression was increased in HNSCC cells after
liprin-α1 knockdown from different biological replicates. Tubulin and vinculin were used as loading controls. Error bar was calculated as standard deviation
from different constructs, and value was considered statistically significant when *P< 0,05 calculated as unpaired student’s t-test. cWestern blot showed
the upregulation of CD82 in breast and HNSCC cell line and SORL1 in HNSCC cell lines. d Immunofluorescence staining showed upregulation and
localization of CD82 to intracellular vesicle-like structures or cell edge in MDA-MB-231 cells after liprin-α1 knockdown. CD82 was at the cell-cell contact sites
and near the cell edge in shPPFIA1 UT-SCC-42B cell colonies grown in three-dimensional collagen I. Scale bar is 10 μm and magnification 63×
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Significance of PPFIA1 amplification to survival of clinical
HNSCC and breast cancer patients
Due to our results showing the association between
liprin-α1 and CD82, we explored the significance of
PPFIA1 amplification in survival of clinical HNSCC and
breast cancer patients from The Cancer Genome Atlas
(TCGA) data. Survival data showed shorter survival for
patients with PPFIA1 amplification when compared to
patients with no alteration in both the HNSCC (35.81
versus 64.78 months, p = 0.0152) and breast cancer data
(125.3 versus 164.3 months, p = 0.00998) (cbioportal,
TCGA-data, Additional file 11: Figure S8) [21, 22].
Discussion
PPFIA1 encoding liprin-α1 shows high correlation be-
tween copy number and gene expression in different
cancer types and is related to metastatic potential and
cell invasive growth in breast carcinoma [1, 11, 12, 23].
The amplification of 11q13 region, where PPFIA1 is lo-
cated, is associated to the presence of metastases also in
Fig. 4 a Immunofluorescence staining of CD82 and liprin-α1 in UT-SCC-42A cells cultured in 2D showed localization of CD82 in intracellular
vesicle-like structures and at the cell membrane after liprin-α1 knockdown (shPPFIA1). Liprin-α1 was localized in invadosome structures or after
the leading edge in shScr control cells. b Immunofluorescence staining of CD82 and liprin-α1 in UT-SCC-42A control (shScr) and liprin-α1 knockdown
(shPPFIA1) cells in 3D culture. In shScr cell colonies, liprin-α1 was located either as cytosolic or on the edges of the cellular outgrowths in adhesion- or
invadosome-like structures. ShPPFIA1 cells showed localization of CD82 mainly at the cell membrane, in cell-cell and in cell-extracellular matrix
contacts. Scale bar is 10 μm, and magnification 63×
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oral squamous cell carcinoma (OSCC) [24]. In the
present study, we demonstrated that liprin-α1 enhances
invasive potential in metastatic HNSCC cells cultured in
3D collagen I matrix, corroborating our previous findings
on the effect of liprin-α1 on cell invasion or invasive
growth of motile cells. In this study, we further investi-
gated the mechanism behind the function of liprin-α1
by performing RNA sequencing of breast cancer and
HNSCC cells cultured in 3D collagen I environment.
When comparing UT-SCC cell lines to metastatic breast
cancer after liprin-α1 knockdown, 6.8% of differentially
expressed genes were shared between HNSCC and breast
cancer, which underlines the heterogeneity of the cancer
cell lines. GSEA data analysis demonstrated liprin-α1 in-
volvement in protein trafficking, modulation of membrane
composition, as well as cell-cell and cell-substrate sig-
naling. These associations suggest that liprin-α1 is an
important player in a variety of different processes related
to cell-cell communication and intracellular protein
transport in HNSCC and breast cancer cells in 3D
environment.
Liprin-α1 knockdown led to upregulation of CD82 cell
surface protein, which inhibits formation of invasive struc-
tures called microprotrusions during cancer cell invasion
[25]. CD82 overexpression correlates with reduced cell
growth, migration, invasion and xenograft tumor growth
in OSCC [26], and CD82 downregulation is associated
with poorer survival in OSCC [27]. Moreover, CD82 has
been proposed to decrease cellular dissemination of
cancerous cells from primary tumor [28] and invasive
potential of different solid tumors (reviewed in [29]). CD82
downregulation associates to increased cell spreading in
dendritic cells [30] supporting previous findings on as-
sociation of liprin-α1 expression to cell edge dynamics
and enhanced cell spreading [14]. When we knocked
down liprin-α1 in HNSCC and breast cancer cells grown
in two-dimensional cell culture, CD82 was located at the
vesicle-like structures and showed partial co-localization
with caveolin-1. In 3D environment liprin-α1 was local-
ized to adhesion or invadosome-like structures or near cell
edge, whereas CD82 was located at the cell edge and
cell-cell contacts after liprin-α1 silencing suggesting that
the localization of liprin-α1 or CD82 are dependent on
environment, matrix availability and cell-cell contacts.
Liprin-α1 is a part of β1-integrin signaling and recyc-
ling [15, 16], while CD82 modulates β1-integrin mat-
uration and integrin-related cell adhesion in cancer
cells [31–33], and is regulated by endocytosis and pal-
mitoylation [34, 35]. In line with this data, caveolin-1,
an important scaffolding protein involved in endo-
cytosis and membrane trafficking, is required for
CD82 mediated EGFR signaling [36]. Most importantly,
we showed in the present work that downregulation of
CD82 by siRNAs partially enhanced invasive capabilities
of metastatic shPPFIA1 HNSCC cells in 3D collagen
providing evidence on the interplay between liprin-α1
and CD82 which is most likely due to the regulative
role of liprin-α1 in cell-cell and cell-extracellular matrix
contacts.
Gene set enrichment analysis provided several clues for
the overall regulatory patterns and genes that are linked to
liprin-α1. Interestingly, sortilin-related receptor 1 (SORL1),
which likely plays a role in endocytosis and sorting and it
has association to Alzheimer’s disease [37, 38], was up-
regulated in liprin-α1 knockdown cells. SORL1 sorting
and quality control occurs in the endoplasmic reticulum
(ER)-Golgi complex, and mutations in SORL1 may pre-
vent trafficking of the protein to the cell membrane due to
defects in ER quality control [39]. Interestingly, our gene
expression and gene set enrichment analysis data revealed
that liprin-α1 is involved in the regulation of the protein
signaling related to endoplasmic reticulum. In addition,
ARRDC3, which is a tumor suppressor and involved in in-
tegrin trafficking [40], was upregulated in breast cancer,
whereas FN1 was downregulated after liprin-α1 knock-
down. FN1 has been correlated to poorer prognosis [41]
and metastasis formation [42] while a recent publication
shows the involvement of liprin-α1 in fibronectin secre-
tion in endothelial cells [16]. In HNSCC, ASAP3 (alias
ACAP4) with a potential role in focal adhesions, β1 integ-
rin recycling and migration [43, 44], was downregulated in
liprin-α1 knockdown cells. Another gene related to adhe-
sion, integrin inhibition and suppression of focal adhesion
formation, SMURF1 [45], was upregulated in liprin-α1
knockdown cells, which is also likely to have anti-tumor
activity [46]. Furthermore, ANXA2, whose expression is
diminished in dysplastic HNSCC [47] was upregulated in
liprin-α1 knockdown cells from HNSCC data.
Our previous data show regulative role of liprin-α1
on vimentin [12] and indeed VIM was upregulated in
HNSCC cells after liprin-α1 knockdown both in 2D
and 3D cell culture platforms. Changes in the pro-
teins related to adhesion and protein recycling under-
lines the important role of liprin-α1 in cell signaling
in 3D environment. Intriguingly, both liprin-α1 and
vimentin have important roles in invadosome function
in cancer cells [12, 13, 48, 49], vimentin being im-
portant in stabilizing and in elongation of mature
invadopodia [49]. There is evidence that invadosomes
are formed in vivo, and the shape of invadosomes
vary depending on the cellular microenvironment
[50]. We showed that in 3D environment liprin-α1 lo-
calized to adhesion- or invadosome-like structures.
Taken together, our GSEA data underlined the role of
liprin-α1 in the cell edge functions of cancer cells
during cell invasion, shown by modifications in CD82
expression as well as by rearrangements in actin cyto-
skeleton after liprin-α1 silencing.
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Studying the translational modifications following
liprin-α1 silencing provided us with better understanding
on liprin-α1 association to metastatic progression of the
cells. Therefore, we next explored how PPFIA1 amplifica-
tion influences the survival of the patients from HNSCC
and breast cancer in clinical data. Interestingly, in The
Cancer Genome Atlas data PPFIA1 alteration was identi-
fied in 189 (36%) of 528 sequenced head and neck squa-
mous cell carcinoma patients, whereas in breast cancer
data set PPFIA1 amplification was identified in 439 (17%)
of 2509 sequenced patients [21, 22]. Survival data showed
shorter survival for altered patients when compared to pa-
tients with no alteration in both the HNSCC and in breast
cancer data [21, 22]. Clinical data emphasizes the import-
ance of PPFIA1 amplification in cancer cell progression,
and as a potential prognostic marker for HNSCC and
breast cancer.
Conclusions
Our study provides novel information regarding liprin-α1
function in cancer cell signaling and strengthens the role of
liprin-α1 in regulating cell edge functions during cell inva-
sion. We present novel insight into liprin-α1 dependent
regulation of different biological processes and of CD82
which links liprin-α1 to metastatic progression of cancer
cells. In conclusion, we show that liprin-α1 controls cell
edge protrusions during invasion and metastasis underlin-
ing importance of liprin-α1 in cancer cell dissemination
and metastatic process of cancer cells.
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Additional file 1: Figure S1. A: UT-SCC-42B stained with vinculin (green)
and liprin-α1 (red) in 3D collagen I matrix. B: Co-localization of F-actin and
liprin-α1 in UT-SCC-19B and UT-SCC-42B (left and middle) or vinculin and
liprin-α1 in 3D UT-SCC-42B (right) cell colonies. Pearson’s co-localization
coefficient and two-channel co-localization maps showing the contribution
of each pixel to the co-localization coefficient. Scale bar 30 μm. (JPG 343 kb)
Additional file 2: Table S1. Overview of gene expression changes in
MDA-MB-231 breast cancer and UT-SCC-42A/B HNSCC cell lines after
liprin-α1 knockdown using three different constructs targeting PPFIA1.
(XLSX 692 kb)
Additional file 3: Table S2. A lists of shared genes from RNA-seq data
comparisons between shPPFIA1 knockdown and shScr control cells from
HNSCC and breast cancer. A: Shared genes between UT-SCC-42A/42B
and MDA-MB-231 cells grown in 3D collagen I. B: Shared genes between
UT-SCC-42A/42B grown in 3D and UT-SCC-24B cells grown in 2D cell culture.
C: Shared genes between MDA-MB-231 grown in 3D and UT-SCC-24B
cells grown in 2D cell culture. D: Shared genes in MDA-MB-231 and UT-
SCC-42A/42B cells grown in 3D and UT-SCC-24B cells grown in 2D cell
culture. (XLSX 22 kb)
Additional file 4: Table S3. Overview of the results from the Gene Set
Enrichment Data analysis from HNSCC and breast cancer cells line comparing
shPPFIA1 knockdown and shScr control cells. (XLSX 491 kb)
Additional file5: Figure S2. A: Collagen contraction assay for MDA-MB-231
cell line was performed with shScr control and two different shPPFIA1
constructs. B: The cultures were quantified by relative area of the colony by
ImageJ, which showed that control cells displayed better contraction of
collagen than knockdown cells. C: Efficiency of liprin-α1 knockdown shown
by western blot. D: MDA-MB-231 control cells formed tighter colonies with-
out matrix in a low adhesion 96-well plate compared to the liprin-α1 knock-
down cell line. (JPG 139 kb)
Additional file 6: Figure S3. A: Downregulation of PPFIA1 and
upregulation of CD82, VIM, and SORL1, which were selected for further studies
in UT-SCC cell lines after liprin-α1 knockdown. B: CD82 (green) upregulation
and localization to vesicle-like structures and cell edge in UT-SCC-42B cell line
after liprin-α1 knockdown shown by immunofluorescence. (JPG 180 kb)
Additional file 7: Figure S4. Caveolin-1 and CD82 partly, but not
prominently co-localized in UT-SCC-42A cells with liprin-α1 knockdown cells
when cultured in 2D. EEA1 and CD82 did not co-localize in the liprin-α1
knockdown cells. Upregulated CD82 localized in different Z-stack plane as
compared to phalloidin positive invadosome cores. (JPG 991 kb)
Additional file 8: Figure S5. Upregulated CD82 co-localized with phalloidin
and ZO-1 in cell-cell contacts after liprin-α1 knockdown in UT-SCC-42A cells in
3D. (JPG 510 kb)
Additional file 9: Figure S6. Knockdown of CD82 by siRNAs. A: Western
blot verified the partial knockdown of CD82 in UT-SCC-42B shPPFIA1_97
cells compared to shPPFIA1_97 cells transfected with ctrl siRNA. B:
Quantification of colony area with three different collagen I gels/condition.
Statistical significance was considered to be significant under P < 0.05, and
error bars were calculated by standard deviations from three replicates. C:
Representative images from colonies transfected with either control siRNA
or CD82 siRNA. (JPG 270 kb)
Additional file 10: Figure S7. A: Vimentin upregulation in UT-SCC-42B
cell line was confirmed by immunoblotting using different shRNA constructs
for PPFIA1. B: Downregulation of keratin 4, 10 and 13 expression levels in
insoluble fraction of the UT-SCC-24B cells after liprin-α1 knockdown. C: Keratin
4 (red) and vimentin (green) localization in shScr and shPPFIA1 UT-SCC-24B
cells. D: Western blot showed the level of knockdown of vimentin in breast
cancer cells. Liprin-α1 protein levels did not alter significantly in control shScr
and shVIM cells, but keratin 13 expression was decreased after vimentin
knockdown. E: Immunofluorescence images for vimentin (green) and
liprin-α1 (red) in MDA-MB-231 and Hs578T breast cancer cell lines and
for vinculin (green) and liprin-α1 (red) in Hs578T breast cancer cell line
after vimentin knockdown. (JPG 480 kb)
Additional file 11: Figure S8. Significance of PPFIA1 alteration on
survival of HNSCC (TCGA, provisional, cBioportal) and breast cancer
(TCGA, METABRIC, cBioportal) patients in The Cancer Genome Atlas
datasets. (JPG 210 kb)
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